Nature CommunicationsNeurosciencePeer-reviewed journal article
Buffering of transcription rate by mRNA half-life is a conserved feature of Rett syndrome models
Deivid C. RodriguesiD, Marat Mufteev, Kyoko E. YukiiD, Ashrut NarulaiD, Wei WeiiD, Alina Piekna, Jiajie LiuiD, Peter PasceriiD, Olivia S. RisslandiD, Michael D. WilsoniD, James EllisiD
Abstract
Models of MECP2 dysfunction in Rett syndrome (RTT) assume that transcription rate changes directly correlate with altered steady-state mRNA levels. However, limited evidence suggests that transcription rate changes are buffered by poorly understood compensatory post-transcriptional mechanisms. Here we measure transcription rate and mRNA half-life changes in RTT patient neurons using RATE-seq, and reinterpret nuclear and whole-cell RNAseq from Mecp2 mice. Genes are dysregulated by changing transcription rate only or half-life only and are buffered when both are changed. We utilized classifier models to understand the direction of transcription rate changes based on gene-body DNA sequence, and combined frequencies of three dinucleotides were better predictors than contributions by CA and CG. MicroRNA and RNA-Binding Protein (RBP) motifs were enriched in 3UTRs of genes with half-life changes. Motifs for nuclear localized RBPs were enriched on buffered genes with increased transcription rate. Our findings identify post-transcriptional mechanisms in humans and mice that alter half-life only or buffer transcription rate changes when a transcriptional modulator gene is mutated in a neurodevelopmental disorder.
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 11
- FWCI
- 1.82
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptional boosting and buffering during neurodevelopment by shifts in mRNA instability
Marat Mufteev, Deivid C. Rodrigues, … James Ellis·bioRxiv·Mar 1, 2023
- The role of N-terminal modification of MeCP2 in the pathophysiology of Rett syndrome
Taimoor I. Sheikh, Alexia Martínez de Paz, … John B. Vincent·Human Molecular GeneticsPeer-reviewed·Jul 26, 2017
- MeCP2 Interacts with the Super Elongation Complex to Regulate Transcription
Jun Young Sonn, Wonho Kim, … Huda Yahya Zoghbi·Science AdvancesPeer-reviewed·Nov 26, 2025
- Early transcriptional signatures of MeCP2 positive and negative cells in Rett syndrome
Yan Li, Ashley G. Anderson, … Huda Yahya Zoghbi·bioRxiv·Jun 26, 2025
- The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes
Linda Scaramuzza, Giuseppina De Rocco, … Nicoletta Landsberger·EMBO Molecular MedicinePeer-reviewed·Mar 5, 2021
- Translational reading frame determines the pathogenicity of C-terminal frameshift deletions in MeCP2: an alternative therapeutic approach
Jacky Guy, Elena Hein, … Adrian Peter Bird·bioRxiv·Aug 31, 2025